Your session is about to expire
← Back to Search
Sulfur Colloid SPECT/CT for Liver Cancer
This trial is studying how well SPECT/CT with technetium Tc-99m sulfur colloid works in measuring liver function in patients with liver cancer.
- Blood Clot
- Liver Cancer
- Intrahepatic Cholangiocarcinoma
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You cannot handle a specific type of scan called SPECT/CT 99mTc-SC.You have liver disease that can be measured, or a blood clot in a blood vessel near a tumor.You have liver cancer and are planning to have radiation treatment or surgery.You should have had a CT or MRI scan within 2 months before joining the study.You can have had different types of treatments before joining the study, including chemotherapy and radiation at the same time.
- Group 1: Diagnostic (SC SPECT/CT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you elaborate on past research involving Single Photon Emission Computed Tomography?
"Currently, 4 investigations investigating Single Photon Emission Computed Tomography are in progress with 1 study being in its concluding Phase 3. Santa Monica is a hub for these experiments; however, there are 7 distinct centres currently running trials concerning this imaging technique."
How many participants is the study looking to recruit?
"Correct. Records on clinicaltrials.gov demonstrate that this scientific investigation, which was originally posted in December 2016, is actively recruiting participants. In total, 60 individuals need to be registered from 2 different medical facilities."
In what scenarios is Single Photon Emission Computed Tomography typically employed?
"Single Photon Emission Computed Tomography is a commonly prescribed intervention for hypovolaemia. It may also be used to assess drainage procedure, pulmonary aspiration of gastric contents, and functioning reticuloendothelial cells in the liver, spleen and bone marrow."
Is this particular experiment a pathbreaking endeavor?
"Since 2008, Single Photon Emission Computed Tomography has been the object of rigorous clinical studies. The very first study was funded by NuRx Pharmaceuticals, Inc., and enrolled 65 participants. After receiving Phase 2 drug approval in 2008, it is now being tested across 5 cities located within one nation through 4 separate trials."
Are recruitment efforts still underway for this clinical trial?
"Indeed, the details posted on clinicaltrials.gov demonstrate that this trial is now enlisting volunteers. The study was initially put up on December 21st 2016 and recently modified on August 16th 2022; they are seeking 60 participants from two different facilities."
Share this study with friends